Navigation Links
HPS Establishes Independent Website for its Patent-Pending Mood-Enhancing Compound Naturally Found in Sea Coral
Date:1/21/2009

SAN JOSE, Calif., Jan. 21 /PRNewswire-FirstCall/ -- Human Pheromone Sciences, Inc. (OTC Bulletin Board: EROX) ("HPS" or "the Company") announced that it has established a website devoted to its newly-announced mood- enhancing compound, ER 303, for which the Company filed Comprehensive Patent Applications with both the U.S. Patent and Trademark Office and the International Bureau of the World Patent Office. On the site, the Company released additional data regarding the testing that was performed on male and female volunteers, which show significant improvement in several aspects of mood enhancement.

"We felt it appropriate to develop this website to respond to requests received about this innovative and previously undeveloped compound, with its origin in sea coral, which has significant emotional impacts on both men and women, enhancing feelings of positive social relationships, personal well- being and social attraction", a Company spokesperson noted. "Hopefully, the data contained on this site will answer initial questions that have been posed since the Company's original announcement", the spokesperson indicated.

In addition to the Company's earlier disclosure, the data included on http://www.ER303.com details the definitive results of the testing that was performed, and confirms that prior to the Company's reproduction of this naturally-occurring compound, it could only be found in coral reefs off the coasts of Newfoundland and in the waters off Brazil's Guiabinha Island.

The Company has previously been granted broad-based worldwide patents for its initial compound, Androstadienone, which has been licensed to leading marketers, including Johnson & Johnson, Avon and Schwarkopf and Henkel and its affiliates.

This news release may contain forward-looking statements that involve risks and uncertainties that could cause results to differ from predicted results. Further information on factors that could affect the Company's results is detailed in the Company's annual report to shareholders on Form 10- KSB for the year ended December 31, 2007, and Form 10-Q for the nine months ended September 30, 2008 as filed with the Securities and Exchange Commission. The Company undertakes no obligation to publicly release the result of any revisions to these forward-looking statements.


'/>"/>
SOURCE Human Pheromone Sciences, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Daiichi Sankyo, Inc. Establishes Subsidiary in Puerto Rico
2. Cystic Fibrosis Foundation Establishes Landmark Patient Assistance Foundation
3. Body-Jet Water-Assisted Liposuction Establishes New Standard for Liposuction and Fat Harvesting
4. Johnson & Johnson Establishes Wellness & Prevention Platform with Acquisition of HealthMedia, Inc.
5. Halleland Health Consulting Establishes URAC Accreditation Program
6. Jenny Craig Establishes License Agreement for Volumetrics(R)
7. Disabled Veteran Establishes Non-Profit, AVHRT, to House Injured Veterans
8. Sonic Innovations Establishes Donation Fund for the Armed Forces Foundation
9. Leading Performance-Enhancing Drug Research Institute Anti-Doping Research (ADR) Establishes Nonprofit Status
10. AmeriCares Establishes Field Hospital in China
11. InterComponentWare Establishes ICW Labs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/20/2017)... Fla. (PRWEB) , ... February 20, 2017 , ... Scrubbing ... Cancer Center in Houston, Dr. Christopher Pezzi remembers the excitement of the surgeon training ... believe they pay us to do this? Don’t tell anyone, but I would do ...
(Date:2/20/2017)... ... February 20, 2017 , ... ... industries, announced Biscom Document Router (BDR), the first IoT device from Biscom designed ... and imaging. Biscom will debut BDR at HIMSS17 and will be ...
(Date:2/20/2017)... ... February 20, 2017 , ... Johns Hopkins All Children's Hospital celebrated a ... out ceremony on Friday marked the halfway point of construction and lifting of the ... 2018, will serve as a center for innovation aimed at finding new discoveries and ...
(Date:2/19/2017)... ... February 19, 2017 , ... Braun Industries will be participating as an ... event will take place February 23-25, 2017 at the Calvin L. Rampton Salt Palace ... with three new ambulances on display. , “JEMS is a leader ...
(Date:2/18/2017)... ... February 17, 2017 , ... ... disruptive innovation in the industry, according to the recent NEJM Catalyst Insights Report ... surveys of the NEJM Catalyst Insights Council, a qualified group of U.S. executives, ...
Breaking Medicine News(10 mins):
(Date:2/20/2017)... , Feb. 20, 2017 Systems ... that creates detailed images of the organs and tissues ... field and radio waves. The technique does not use ... of brain function or growth of cancer. MRI is ... neurology, cardiology, oncology, musculoskeletal, and orthopedics. Hence, MRI helps ...
(Date:2/20/2017)... -- Report analyzes the worldwide markets for Infusion ... Ambulatory Infusion Pumps, Enteral Feeding Pumps, Insulin Infusion ... and Syringe Infusion Pumps. The report provides separate ... Asia-Pacific, Latin America, and Rest of World. ... Annual estimates and forecasts are provided for ...
(Date:2/20/2017)... This report analyzes the worldwide markets for Human ... comprehensive analytics for the US, Canada , ... Asia-Pacific , and Rest of World. ... Annual estimates and forecasts are provided for the period ... for these markets. Market data and analytics are derived from ...
Breaking Medicine Technology: